A 2.6 Å structure of a serpin polymer and implications for conformational disease

Journal of Molecular Biology

Volumn 293, Issue 3, 1999, Pages 449-455

  Huntington, James A ^a   Pannu, Navraj S ^a   Hazes, Bart ^a   Read, Randy J ^a   Lomas, David A ^a   Carrell, Robin W ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

Amyloid; Polymer; Serpin; Structure; 1 antitrypsin

Indexed keywords

ALPHA 1 ANTITRYPSIN; AMYLOID; SERINE PROTEINASE INHIBITOR; PEPTIDE FRAGMENT; POLYMER; RECOMBINANT PROTEIN;

ALZHEIMER DISEASE; ARTICLE; EMPHYSEMA; GENE MUTATION; HUMAN; LIVER CIRRHOSIS; POLYMERIZATION; PRIORITY JOURNAL; PROTEIN STRUCTURE; THROMBOSIS; AMINO ACID SEQUENCE; CHEMICAL STRUCTURE; CHEMISTRY; CRYSTALLIZATION; GENETICS; METABOLISM; MOLECULAR GENETICS; PATHOLOGY; PROTEIN SECONDARY STRUCTURE; SENILE PLAQUE; TIME; X RAY CRYSTALLOGRAPHY;

ALPHA 1-ANTITRYPSIN; AMINO ACID SEQUENCE; CRYSTALLIZATION; CRYSTALLOGRAPHY, X-RAY; HUMANS; LIVER CIRRHOSIS; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; PEPTIDE FRAGMENTS; POLYMERS; PROTEIN STRUCTURE, SECONDARY; RECOMBINANT PROTEINS; SENILE PLAQUES; TIME FACTORS;

EID: 0032589794     PISSN: 00222836     EISSN: None     Source Type: Journal    
DOI: 10.1006/jmbi.1999.3184     Document Type: Article

References (32)

1. 1-antichymotrypsin in the brain amyloid deposits of Alzheimer's disease. Cell. 52:1988;487-501.
2. Bacon D., Anderson W. F. A fast algorithm for rendering space-filling molecule pictures. J. Mol. Graph. 6:1988;219-220.
3. Bennett M. J., Choe S., Eisenberg D. Domain swapping: entangling alliances between proteins. Proc. Natl Acad. Sci. USA. 91:1994;3127-3131.
4. Brünger A. T., Adams P. D., Clore G. M., Delano W. L., Gros P., Grosse-Kunstleve R. W., Jiang J. S., Kuszewski J., Nilges M., Pannu N. S., Read R. J., Rice L. M., Simonson T., Warren G. L. Crystallography & NMR system: a new software suite for macromolecular structure determination. Acta Crystallog. sect. D. 54:1998;905-921.
5. Carrell R. W., Lomas D. A. Conformational disease. Lancet. 350:1997;134-138.
6. Chang W. S., Wardell M. R., Lomas D. A., Carrell R. W. Probing serpin reactive-loop conformations by proteolytic cleavage. Biochem. J. 314:1996;647-653.
7. Chang W. S., Whisstock J., Hopkins P. C., Lesk A. M., Carrell R. W., Wardell M. R. Importance of the release of strand 1C to the polymerization mechanism of inhibitory serpins. Protein Sci. 6:1997;89-98.
8. Acta Crystallog. sect. D. 50:1994;760-763.
9. 1-antitrypsin. Nature Struct. Biol. 3:1996;676-681.
10. 1-antitrypsin, structure and implications for function and metabolism. Protein Eng. 2:1989;407-415.
11. Harper J. D., Lansbury P. T. J. Models of amyloid seeding in Alzheimer's disease and scrapie: mechanistic truths and physiological consequences of the time-dependent solubility of amyloid proteins. Annu. Rev. Biochem. 66:1997;385-407.
12. Jiang J. S., Brünger A. T. Protein hydration observed by X-ray diffraction. Solvation properties of penicillopepsin and neuraminidase crystal structures. J. Mol. Biol. 243:1994;100-115.
13. Kraulis P. J. Molscript - a program to produce both detailed and schematic plots of protein structures. J. Appl. Crystallog. 24:1991;946-950.
14. Lansbury P. T. J. Evolution of amyloid: what normal protein folding may tell us about fibrillogenesis and disease. Proc. Natl Acad. Sci. USA. 96:1999;3342-3344.
15. Leslie A. W. G. Joint CCP4 and ESF-EACMB Newsletter on Protein Crystallography. 1992;Daresbury Laboratory, Warrington.
16. 1-proteinase inhibitor. Crystal structure analysis of two crystal modifications, molecular model and preliminary analysis of the implications for function. J. Mol. Biol. 177:1984;531-557.
17. 1-antitrypsin accumulation in the liver. Nature. 357:1992;605-607.
18. 1-Antitrypsin Siiyama (Ser53→Phe). Further evidence for intracellular loop-sheet polymerization. J. Biol. Chem. 268:1993;15333-15335.
19. 1-antichymotrypsin and apolipoprotein E promote assembly of Alzheimer β-protein into filaments. Nature. 372:1994;92-94.
20. 1-antitrypsin and liver cirrhosis. J. Clin. Invest. 103:1999;999-1006.
21. 1-proteinase inhibitor probed by limited proteolysis. Biochemistry. 31:1992;2720-2728.
22. McRee D. E. A visual protein crystallographic software system for X11/XView. J. Mol. Graph. 10:1992;44-46.
23. Merritt E. A., Murphy M. E. P. Raster3d version-2.0 - a program for photorealistic molecular graphics. Acta Crystallog. sect. D. 50:1994;869-873.
24. Mottonen J., Strand A., Symersky J., Sweet R. M., Danley D. E., Geoghegan K. F., Gerard R. D., Goldsmith E. J. Structural basis of latency in plasminogen activator inhibitor-1. Nature. 355:1992;270-273.
25. Navaza J. AMoRe - an automated package for molecular replacement. Acta Crystallog. sect. A. 50:1994;157-163.
26. 1-Antitrypsin Pittsburgh (Met 358 Arg), leads to a fatal bleeding disorder. New Engl. J. Med. 309:1983;694-698.
27. Pannu N. S., Read R. J. Improved structure refinement through maximum likelihood. Acta Crystallog. sect. A. 52:1996;659-668.
28. Read R. J. Model phases: probabilities and bias. Methods Enzymol. 277:1997;110-128.
29. 1-antitrypsin by a peptide sequentially similar to β-strand s4A. Eur. J. Biochem. 194:1990;51-56.
30. Stein P. E., Carrell R. W. What do dysfunctional serpins tell us about molecular mobility and disease? Nature Struct. Biol. 2:1995;96-113.
31. Wright H. T., Scarsdale J. N. Structural basis for serpin inhibitor activity. Proteins: Struct. Funct. Genet. 22:1995;210-225.
32. Xue Y., Bjorquist P., Inghardt T., Linschoten M., Musil D., Sjolin L., Deinum J. Interfering with the inhibitory mechanism of serpins: crystal structure of a complex formed between cleaved plasminogen activator inhibitor type 1 and a reactive-centre loop peptide. Structure. 6:1998;627-636.